title: Simultaneous subacute stent thrombosis of two sirolimus-eluting stents in a patient treated by ReoPro, thrombus aspiration and triple anti-platelet agents.
abstract: Effective anti-platelet treatment has a key role in the prevention of stent thrombosis in the drug-eluting stent (DES) era. However, despite of the use of anti-platelet agents, stent thrombosis occurs in approximately 1% of patients, with an increased likelihood of occurrence in high-risk patients or complex lesion subset of patients [1-4]. According to the previous report, triple anti-platelet therapy (aspirin+clopidogrel+cilostazol) seemed to be more effective in preventing thrombotic complications after stenting than dual anti-platelet agent [5]. But, in this report, we present a patient with subacute stent thrombosis (ST) involving two different arteries simultaneously under the use of triple anti-platelet regimen.
authors.forename: Jae-Youn
authors.initials: JY
authors.lastname: Moon
authors.forename: Jong Won
authors.initials: JW
authors.lastname: Chung
authors.forename: Ju Han
authors.initials: JH
authors.lastname: Kim
authors.forename: Young Keun
authors.initials: YK
authors.lastname: Ahn
authors.forename: Myung Ho
authors.initials: MH
authors.lastname: Jeong
mesh_terms: D003328:Coronary Thrombosis / Q000628:therapy*; D054855:Drug-Eluting Stents; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D020123:Sirolimus / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D007166:Immunosuppressive Agents; D010975:Platelet Aggregation Inhibitors; D020123:Sirolimus